The absence of SIRT3 abrogates the beneficial effects of JT on renal function, oxidative stress markers, and mitochondrial ultrastructure, highlighting its essential contribution to the therapeutic potential of JT in CKD. Here, SIRT3 is linked to chronic kidney disease.